Pinsent Masons Advises Accord Healthcare in Exclusive Licence Agreement with Myovant Sciences to Commercialise ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe
14 Jun 2022 | 03:35 pm |
Pinsent Masons represented Accord Healthcare Ltd in an exclusive license agreement with Myovant Sciences to commercialise relugolix, Myovant’s advanced hormone-sensitive prostate cancer treatment, under the trade name ORGOVYX® in the European Economic Area, United Kingdom, Switzerland and Turkey.
Under the terms of the agreement, Myovant will receive an upfront payment of US$50 million, and is eligible to receive milestones which could total up to a further US$90.5 million. Myovant will continue to lead the global development of relugolix and provide initial product supply to Accord. Accord will be responsible for certain local clinical development, all commercialization for its territories, and has the option to manufacture relugolix in the future.
The Pinsent Masons transactions team was led by Life Sciences Transactions partner Gina Bicknell, with primary support from solicitor Kiah York and legal director Mario Subramaniam.
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises Erisbeg on proposed acquisition of PageOne Communications
Multinational law firm Pinsent Masons has advised Dublin-headquartered private equity firm Erisbeg on the agreement to acquire the entire issued share capital of PageOne Communications from the Capita Group.
Pinsent Masons advises Breedon Group on acquisition of Robinson Quarry Masters and LSE Listing
Multinational law firm Pinsent Masons has advised Breedon Group on the acquisition of Robinson Quarry Masters, a Northern Ireland based family-run quarrying and concrete block business.
Pinsent Masons advises Regenerate in the launch of its European regenerative agriculture fund
Multinational law firm Pinsent Masons has advised Regenerate Asset Management in the launch of the Regenerate European Sustainable Agriculture Fund.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons appoints life sciences patent expert in its London office
Multinational law firm Pinsent Masons has hired European and UK life sciences partner Kristina Cornish into its London office.
Pinsent Masons advises UMS Consulting on its acquisition by Expleo
Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.
Pinsent Masons launches parallel trade monitoring platform for life sciences sector
Multinational law firm Pinsent Masons launches innovative online tool to help life sciences organisations grappling with parallel trade management.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]